Wnt signaling plays a central role in tumor initiation and tumor progression. Mutations in Wnt pathway components, such as the tumor suppressor APC, lead to malignant transformation. While previous studies focused on Wnt-related changes in cancer cells, the impact of aberrant Wnt signaling on the tumor microenvironment is only beginning to emerge. In order to investigate the role of increased Wnt secretion on tumor growth and the microenvironment, we generated a novel germ cell tumor model by overexpressing the Wnt secretion factor Evi/Wls in mouse embryonic stem cells. Evi-overexpressing teratoma were characterized by enhanced tumor growth in supporting a tumor-promoting role of Wnt secretion. Interestingly, enhanced Evi expression correlated with impaired immune cell recruitment. Specifically, T-and B-cell infiltration was reduced in Evi-overexpressing teratomas, which was independent of teratoma size and differentiation. Our study suggests that Wnt secretion impairs immunosurveillance. Since immune cell infiltration has been shown to have prognostic value, the levels of secreted Wnt activity might impact the efficiency of cancer immunotherapy.
Introduction
Cells of the tumor microenvironment exert context-dependent proand anti-tumorigenic functions (de Visser et al., 2006; Hanahan and Weinberg, 2011) . Tumor-infiltrating leukocytes execute critical functions within the complex interactions of tumor cells with their microenvironment. Immunosurveillance mechanisms within the tumor stroma enable the immune system to recognize transformed cells in order to initiate mechanisms of their inhibition or elimination (Dunn et al., 2002; Dunn et al., 2004; Schreiber et al., 2011) . During immunosurveillance, cells of the innate and the adaptive immune system cooperate to prevent the growth of neoplastic tissues (Mittal et al., 2014) . The cascade starts with an inflammatory signal produced by the tumor cells, which leads to the recruitment of natural killer (NK) cells, macrophages and dendritic cells (DC), followed by T-cell infiltration and activation of their cytotoxic function.
Recent meta-analyses of solid tumors have shown that the CD3 + T cells infiltration correlates with good prognosis (Gooden et al., 2011; Hwang et al., 2012; Mittal et al., 2014; Nakano et al., 2001; Sato et al., 2005; Sharma et al., 2007) . However, it is an open question why some tumors are highly infiltrated by T cells and others are not. Recent reports suggest that Wnt/β-catenin signaling in melanoma impairs the antitumor immune response and thereby supports cancer cell-induced immunosuppression (Spranger et al., 2015; Yaguchi et al., 2012) . Thus, the better understanding of the involved signaling mechanisms may provide insights into the immune escape mechanisms of tumor cells.
The highly conserved transmembrane molecule Evi/Wls/Gpr177 is an essential component of the Wnt secretion machinery (Banziger et al., 2006; Bartscherer et al., 2006) . It is required for the exocytosis of Wnt proteins acting as a Wnt cargo receptor by shuttling between the Golgi, the plasma membrane and endosomal compartments (Bartscherer and Boutros, 2008) . Evi is a single-gene family in vertebrates (Jin et al., 2010; Port and Basler, 2010) . Thus, it has been assumed that Evi is involved in the secretion of all Wnt proteins. Correspondingly, Evi depletion globally affects Wnt signaling with consequences for canonical as well as non-canonical Wnt signaling. This, in turn, can be exploited as a unique experimental tool to modulate Wnt signaling through the regulation of Wnt ligand secretion. Genetic inactivation of Evi in mice results in embryonic lethality due to disruption of axial patterning with missing mesoderm and primitive streak formation Fu et al., 2009) .
Embryonic stem cells (ESCs) are widely used to study early differentiation processes (Posfai et al., 2014) . They also hold promise for therapeutic approaches in the field of regenerative medicine (Dressel, 2011; Dressel et al., 2008; Song et al., 2015; Tang and Drukker, 2011 ). Yet, immune rejection resulting from mismatch histocompatibility is a potential limitation of stem cell-based therapies, restricting the rate of successful transplantation (Zhao et al., 2011; Jin et al., 2015) . Moreover, Stem Cell Research 17 (2016) 607-615 ESC transplantation may hold the risk of teratoma formation because undifferentiated ESCs give rise to teratomas, which resemble benign tumors that consist of tissues derived from the three embryonic germ layers (Przyborski, 2005; Lee et al., 2013) . Accordingly, teratoma formation assays need to be performed to confirm ESC pluripotency in a complex in vivo environment. Teratoma assays are also pursued as a model to investigate the crosstalk between ESCs and stromal cells (Przyborski, 2005; Dressel, 2011) . We previously generated Evi-overexpressing mouse ESCs (Evi-GOF) via knockin into the ROSA26 locus to study Wnt secretion in ESCs (Augustin et al., 2012) . Evi-GOF ESCs showed enhanced Wnt activity, which had no effect on ESC pluripotency and viability. Teratoma experiments with Evi-GOF ESCs confirmed pluripotency characterized by meso-, endo-and ectodermal lineage differentiation although Evi-GOF ESCs revealed a preference for cardiomyocyte differentiation. Based on these findings, the present study was aimed at investigating Evi during teratoma formation in order to clarify the role of Wnt secretion in teratoma-stroma interactions in a definite genetic setting.
Results

Evi overexpression leads to larger teratomas in syngeneic mice and promotes cardiogenic differentiation
ESCs express a repertoire of Wnt ligands, which activate canonical and non-canonical Wnt signaling cascades. As a cargo-receptor, Evi acts as a gatekeeper to release or block Wnt secretion. Increased levels of the cargo-receptor have been detected in different tumor entities (Augustin et al., 2012; Voloshanenko et al., 2013; Lu et al., 2015) . Accordingly, Evi overexpression (Evi-GOF) leads to a global increase of secreted Wnt proteins and represent a model of enhanced Wnt signaling. Evi-GOF ESCs ectopically express Evi-YFP, which is localized to the secretory pathway (Fig. 1A) . FACS-based analysis of ESCs confirmed the surface expression of Evi-YFP, indicating proper cellular trafficking of Evi-YFP ( Fig. 1B) . Western blots of ESC supernatants showed increased Wnt5a/5b secretion of Evi-GOF ESCs, which was abolished in the presence of LGK947 (Fig. 1C ). Previous results showed an increased Wnt-reporter activity of Evi-GOF ESCs (Augustin et al., 2012) . Accordingly, LRP6, the co-receptor of Frizzled, revealed higher phosphorylation in Evi-GOF ESCs compared to control cells, which was prevented after LGK947 treatment ( Fig. 1D ). Likewise, expression of the Wnt target gene Axin2 was increased ( Fig. 1E ).
Wnt signaling has been shown to support ESC maintenance. Therefore, we investigated the expression of the pluripotency markers Oct4, Nanog, Sox2, Rex1 as well as Epi-stem cell marker Claudin1 and early differentiation markers CD133 and Fgf5 (Fig. 1F, G) . Enhanced Wnt secretion resulted in no significant changes in their gene expression. Similarly, protein expression of Nanog, SSEA1 and Oct4 was unchanged based on FACS analysis indicating no major alterations in the pluripotency network of Evi-GOF ESCs. Moreover, enhanced Wnt secretion had no effect on the viability and growth of cultured Evi-GOF ESCs (Fig. 1H ). Similar growth curves were observed in the presence of low serum concentrations (5%) or in the absence of LIF (data not shown).
Subcutaneous injection of Evi GOF and control ESCs in syngenic recipients (129P2/OlaHsd) were performed to generate teratomas and analyze the differentiation potential if ESC in vivo. Monitoring of tumor growth over time revealed larger tumors in Evi GOF ESCs ( Fig.  2A ). Evi-YFP expression was detected in Evi-GOF teratoma sections ( Fig. 2B ). Labeled cells showed prominent perinuclear and surface staining and were clearly distinguishable from unlabeled host-derived stromal cells (Fig. 2B ). Histological analysis of teratomas was performed to assess the differentiation potential of the injected ESCs. H&E stained sections showed characteristic structure of endo-, meso-and ectodermal differentiation ( Fig. 2C ). Proliferation of tumor cells was not altered as evidenced by EdU-incorporation experiments (Fig. 2D ). Active caspase-3 labeling showed reduced apoptosis rate in Evi-GOF teratomas. However, it was not significant. ( Fig. 2E) .
In order to understand the differences between in vitro and in vivo growth, we performed expression profiling of teratomas from Evi-GOF and control ESCs. RNA from teratomas was isolated and analyzed by array-based expression profiles to study cellular and molecular mechanisms underlying Evi-GOF teratoma development. A set of 18 genes was significantly upregulated and 123 genes were downregulated in Evi-GOF teratomas (absolute value of log 2 fold change N 1; adj. pvalue b 0.05) (Fig. 3A) . Tissue-related expression analysis of the upregulated genes based on TiGER profiles (http://bioinfo.wilmer.jhu.edu/ tiger/) showed that 61% of the genes had a muscle and heart association, whereas 39% of the genes were ubiquitously expressed or had other tissue preferences, supporting the concept that Evi-GOF ESCs reinforced mesodermal differentiation to result in enhanced muscle development ( Fig. 3B ). Similar results were reported after Wnt1 overexpression (Weisel et al., 2010) or sustained treatment of ESCs with Wnt3a or GSK-inhibitor (Bakre et al., 2007) . The list of upregulated genes related to muscle and heart development is summarized in Fig. 3C .
Reduced expression of immune-modulatory genes in Evi-overexpressing teratomas
Among the downregulated genes, the highest enrichment was observed in genes categorized as immunity and defense (43% of the downregulated genes) as well as signal transduction (30% of the downregulated genes) ( Fig. 3D) . Similarly, genes involved in T-and Bcell-mediated immunity, as well as innate immunity were differentially expressed suggesting an altered immune response ( Fig. 3D ). Among others, the genes coding for three CD3 chains (CD3γ, CD3δ, CD3ε)part of the TCR-CD3 complexwere downregulated about 3-fold ( Fig.  3E ). The CD79b antigen, part of the B lymphocyte antigen receptor, was also downregulated ( Fig. 2E ). Next, we studied if surface markers involved in T cell activation and survival were differentially expressed in Evi-GOF and control teratomas. The B7 family members CD80 (B7-1) and CD86 (B7-2) work in tandem to activate T cells via binding to CD28 co-receptor. Following activation, the inhibitory receptor CTLA-4 is induced in T cells, which compete with CD28 for CD80 and CD86 ligands and provided an inhibitory signal to stop T cell activation. In contrast to CD86, CD80 expression was reduced in Evi-GOF teratomas suggesting an imbalance in T cell activation in Evi-GOF tumors compared to controls ( Fig. 3F ). However, CTLA-4, PD-L1 and MHC class II and I markers were not significantly changed, suggesting that no major differences regarding tumor recognition by the immune system were apparent ( Fig. 3F ). Imunohistochemical analysis against MHC class II revealed heterogeneous but similar staining pattern ( Fig. 3G ). This result might be due to the fact, that embryonic stem cells are non-cancer cells but develop benign teratomas composed of cells resembling normal derivatives and therefore, other than tumor cells, do not use mechanisms to become less immunogenic. Further detailed quantitative analysis on marker gene expression would be necessary to confirm this conclusion.
Evi overexpression affects teratoma-immune-cell crosstalk
Expression studies showed that Evi-overexpressing ESCs favored a cardiomyocyte gene expression profile, and that immune regulatory genes were downregulated. Enhanced muscle differentiation might be associated with an altered immune response indicating that the cardiomyocyte lineage itself and not the Wnt overexpressing teratoma cells in general is linked to reduced immune cell crosstalk. Therefore, we compared the expression of the cardiomyocyte marker troponin C type 1 (Tnnc1) and the skeletal muscle marker myosin heavy chain 8 (Myh8) as a surrogate marker of cardiomyocyte differentiation, with the expression pattern of the immune cell markers CD3 (T cells) and CD19 (B cells). The correlation (R 2 ) between Myh8 and Tnnc1 with CD3 or CD19 was not significant indicating that the expression of immune system markers was not affected by altered teratoma differentiation in the Evi-GOF tumors (Fig. S1A ).
As shown above, Evi-GOF teratoma were larger than control tumors ( Fig. 2B ). We therefore analyzed whether the infiltration of immune cells in general was dependent on teratoma size. FACS-based analysis of control teratoma tissue was performed after 27 days of growth. We analyzed the percentage of CD45 + and CD3 + populations from total teratoma cells harvested from tumors of various sizes ranging from 0.4 mg to 0.9 mg ( Fig. S1B ) and found no significant correlation between the number of CD45 + and CD3 + cells and tumor weight.
Given that Evi-GOF teratomas showed predominately down-regulation of genes, which were functionally related to immunity and defense, we hypothesized that Evi expression may affect immune cell infiltration. Therefore, we FACS-profiled the leukocytes that had infiltrated the teratomas. We found that the number of CD45 + cells was 2-fold higher in the control teratomas compared to Evi-GOF teratomas (Fig.  4A ). The data indicates that constitutive overexpression of Evi in ESCs suppressed teratoma immune cell infiltration.
To further investigate the frequency of leukocyte subpopulations in Evi-GOF and control teratomas, we performed FACS profiling distinguishing the infiltrated cell numbers of lymphocytes and myeloid populations. CD45 + subpopulation analysis revealed about 50% reduction in CD3 + T cells as well as CD19 + B cells, whereas F4/80 + , Gr1 − macrophages, Gr1 + , CD11b + granulocytes and CD49b + , CD3 − NK cells were not significantly altered (Fig. 4A ). The ratio of T-to B cells in Evi-GOF tumors was unaltered compared to control tumors (data not shown), indicating that both T-and B cells were affected. Immunohistochemical analysis of CD3 + cells confirmed the reduced T-cell recruitment in Evi-GOF teratomas (Fig. S2A ).
If the tumor-promoting role of Wnt secretion relied on reduced lymphocyte infiltration, persistance and/or impaired T cell activation, the growth advantage of Evi-GOF teratomas grown in immune-compromised Nod/SCID mice, which are deficient in mature T and B cells, should be lost. Indeed, in Nod/SCID mice, tumor sizes (and lymphoid immune infiltration) of Evi-GOF-and control tumors were comparable, supporting the hypothesis that exacerbated Wnt secretion impaired the antitumor immune surveillance of the adaptive immune system (Fig.  4B , C), rather than conferring an intrinsic growth advantage. Subsequent analysis of CD4 + and CD8 + T cell subsets revealed similar distribution in Evi-GOF and control tumors (Fig. 4D ). The CD4 + /CD8a + ratio was also indistinguishable in both teratoma types ( Fig. S2B ). Further analysis of T cells regarding CD4 + effector memory (T EM : CD44 hi , CD62L − ), central memory (T CM : CD44 hi , CD62L + ), and naïve (T N : CD44 − , CD62L + ) subpopulations showed no changes in Evi-GOF teratomas compared to controls (Fig. 4E) . The profiling of CD8 + cells revealed no significant alterations in T EM and T CM subpopulations whereas the fraction of naïve cells in Evi-GOF teratomas was about 50% reduced ( Fig. 4F) . Similarly, the activated T cell populations expressing CD69 + were not altered in Evi-GOF teratomas (Fig. S2C) . The ability of CD4 + T cells to exert effector functions depends on their differentiation. Wnt/β-catenin signaling regulates lineage fate decisions in both the thymus and in peripheral lymphoid tissue and it enhances the survival of regulatory T (Treg) cells (Ding et al., 2008) (Notani et al., 2010) . Interestingly, the fraction of CD4 + , CD25 + , FoxP3 + regulatory T cells was significantly increased in Evi-GOF teratomas (Fig. 4G) . Similarly, the frequency of IL17-producing CD4 + Th17 cells was elevated in Evi-GOF teratomas supporting the idea that Wnt signaling enhanced Th17 differentiation ( Fig. 4H) (Ma et al., 2011; Dai et al., 2016; Muranski et al., 2011) . Next, we asked for extracellular factors responsible for Th17 differentiation. Stimulating naïve T cells with TGF-β and IL6 is sufficient to induce IL17 producing cells (Ma et al., 2011) . Q-PCR analysis of IL6 expression in Evi-GOF and control tumors revealed almost 2fold upregulation of IL6 in Evi-GOF teratomas suggesting that IL6-Stat3 signaling cascade is more pronounced in Evi-GOF teratomas and might contribute to enhanced Th17 differentiation.
In order to investigate the correlation of Evi expression and leucocyte markers in tumor patient biopsies we performed expression analysis of cancer profiles. Using the R2 -Genomics Analysis and Visualization Platform we analyzed the co-expression of Evi and leucocyte markers (CD45, CD3ε, CD3δ, CD4, CD8a, F4/80, CD19) in colon cancer patient cohorts (Tumor Colon Sieber 315 Mas5.0-u133p2, Fig. S3A ). Our analysis revealed that tumor samples with high Evi expression showed low expression of leukocyte markers indicating that Wnt signaling interferes with the tumor-immune crosstalk in mouse and human tumor tissues. Similar results were obtained with a second colon cancer database The present study was based on a novel mouse teratoma model. Accordingly, we analyzed Evi expression in a human Korkola Seminoma tumor data set, which includes different germ cell tumor classes (embryonal carcinoma, mixed germ cell tumor, seminoma, teratoma, yolk sack tumor; TCGA, Oncomine) ( Fig. S3B) . Evi was upregulated in teratomas (fold change 3.579, p-value 3.55E-8) suggesting that teratomas reflect another tumor entity with high Wnt importance. Further studies are necessary to decipher a potential role of Evi in human teratoma immune cell recruitment.
Discussion
ESCs have the potential to differentiate in all types of cells. In vivo application of undifferentiated ESCs leads to teratoma formation (Dressel et al., 2008; Song et al., 2015) . A recent screening study identified an involvement of Wnt signaling in the transition from benign to malignant teratocarcinoma growth (Liu et al., 2012) . Moreover, upregulated Evi expression was found in human teratomas supporting the hypothesis that Evi may contribute to germ cell tumor progression. The Evi-transgenic ESC line reported in this study provides a novel research tool to study teratoma formation. Evi-GOF teratomas showed enhanced tumor growth demonstrating a tumor-promoting role of Evi in ESCs. Correspondingly, previous experiments in glioblastoma and colorectal tumor cells had shown that loss of Evi resulted in inhibition of tumor growth after xenotransplantation (Augustin et al., 2012; Voloshanenko et al., 2013) .
The host immune response has been identified as a critical regulator of tumor development and progression (Dunn et al., 2004; Fridman et al., 2013; Hadrup et al., 2013) . Several types of immune cells participate in immunosurveillance by direct killing or production of cytokines. Our expression profiling experiments revealed that the majority of genes related to immunity and defense were significantly downregulated in Evi-GOF teratomas. Accordingly, less CD45 + leukocytes had infiltrated Evi-GOF teratomas. Most notably, we observed a 50% reduction of CD3 + T cells in Evi-GOF teratomas. Low densities of both CD8 + cytotoxic T cells and CD45RO + memory T cells are associated with poor clinical outcome (Fridman et al., 2013; Becht et al., 2014; Hadrup et al., 2013) . The results of our teratoma experiments support a model whereby high Wnt activity facilitated the escape from the anti-tumor immune control by T cell exclusion. Recent results on Wnt/β-catenin signaling in melanoma have revealed a correlation of canonical Wnt signaling with lack of T-cell infiltration in mouse models as well as in human patient biopsies suggesting a similar role of Wnt signaling in different types of tumors (Spranger et al., 2015) . Our analysis revealed no overt changes in T cell activation or effector differentiation, indicating that excessive Wnt signaling impairs T cell recruitment and/or tumor infiltration, rather than intratumoral T cell activation. Alternatively, the moderate Evi overexpression in ESCs via the Rosa26 promoter was insufficient to challenge the balance of these T cell subsets. Regardless of the exact mechanism, elevated Wnt levels promote increased tumor growth and this effect is mediated through attenuated immune surveillance. The role of Wnt signaling in mature T cell differentiation is still controversially discussed. Recent publications using pharmacological or genetic approaches support a role for β-catenin as well as the β-catenin downstream transcription factor TCF-1 (transcription factor 7) in memory T cell development (Gattinoni et al., 2009; Zhao et al., 2010) . Whereas other reports showed that expression of stabilized or deleted β-catenin was dispensable in functional memory T cell differentiation (Prlic and Bevan, 2011; Driessens et al., 2010) . It is of note that TCF-1 can be activated independently of β-catenin cooperation and therefore does not reflect in all cases exclusive Wnt response (Grumolato et al., 2013; Sprowl and Waterman, 2013) . Similarly, studies addressing Wnt/βcatenin signaling in Treg and Th17 function showed on the one hand that stable β-catenin expression in Tregs supports Treg survival and immune response (Ding et al., 2008) , whereas TCF-1 deficient mutants revealed stronger suppressive ability of (van Loosdregt et al., 2013) . Our teratoma analysis showed an increase in CD4 + CD25 + FoxP3 + Tregs population in Evi-GOF tumors indicating that enhanced Wnt secretion supports Treg availability. Further experimental analyses will be necessary to clarify whether this phenotype correlates with β-catenin or β-catenin-independent Wnt signaling in T cell populations. Tregs suppress inflammatory mechanisms and thereby attenuate inflammation-associated tumor progression. Otherwise regulatory T cells also inhibit anti-tumor T cell responses, thereby supporting cancer escape from immune surveillance. These different functions are probably driven by different Treg subsets, which might depend on the cancer type and mutation status. (Blatner et al., 2012; Keerthivasan et al., 2014) . Recent reports showed that active Wnt/β-catenin signaling in Tregs correlates with promotion of colon cancer (Keerthivasan et al., 2014) . Further studies are necessary to address this issue in other Wnt-related cancer settings. Moreover, several reports exist, which delineate a role of Wnt signaling in Th17 differentiation during T cell development and mature T cell differentiation (Ma et al., 2011; Dai et al., 2016; Muranski et al., 2011) . Our results showed an increase in IL17 producing CD4 + T cells in Evi-GOF teratomas indicating that enhanced Wnt secretion is involved in elevated Th17 response. The supportive or inhibitory role of Th17 in malignancy is still a matter of debate suggesting that Th17 cells play a dynamic role in cancer immunity depending on the type of inflammatory response and cancer (Martin et al. 2012; Wang et al., 2009; Iida et al., 2011) . Recent reports showed that constitutive activation of β-catenin promotes chromatin accessibility and target gene expression for Th17 commitment, which sustained pathogenic inflammation and predispose to cancer (Keerthivasan et al., 2014) . Our phenotypical analyses tend towards the same direction. Nevertheless additional studies are necessary to enroll a more detailed leukocyte population analysis including expression pattern of target genes and cytokines as well as Wnt signal activity.
Previous studies have focused on the analysis of tumor infiltrating T cells. In turn, much less is known about the role of B cells in modulating the immune response to solid tumors (Nelson et al., 2010) . It has been shown for melanoma and several other types of tumors that B cell density correlates with T cell density indicating that B cells support the antitumor immune response (Zirakzadeh et al., 2013) . Accordingly, our study also revealed a concomitant reduction of tumor-infiltrating T and B cells.
In conclusion, the identification of Wnt secretion as a regulator of teratoma growth and immune cell infiltration may have profound impact for the molecular understanding of tumor -immune cell crosstalk with possible translational relevance. Future work will have to unravel the underlying signaling mechanisms regulating the escape from the anti-tumor immune response in order to contribute to the further advancement of cancer immunotherapies.
Material and methods
Cell culture, cell lines, constructs, generation of stable ESC
Evi-GOF ESCs were generated and maintained as previously described (Augustin et al., 2012 ) (genetic background: 129P2/OlaHsd). 6 independent lines were generated. At least two lines per genotype were investigated to exclude clone-specific artifacts. Briefly, ESCs were cultured on mitomycin C inactivated feeder cells (MEFs) in LIF supplemented ESC medium (DMEM high glucose (Gibco) supplemented with 15% FCS (PAN Biotech), 1% Penicillin / Streptomycin (Invitrogen), 2 mM Glutamine (Invitrogen), 100 μM β-mercaptoethanol (Sigma), 1 mM MEM-sodium pyruvate (Invitrogen), 1% non-essential amino acids (Invitrogen), and 1000 U/ml Leukemia Inhibitory factor (LIF, Millipore)) (Lin and Talbot, 2011) . ESCs were passaged on gelatinecoated plates to deplete MEFs and used for experiments after 3-5 passages on gelatine-coated plates. ESCs were cultured at 37°C, 5% CO 2 and passaged 1:3 every 2-3 days.
Cell viability
To assess cell viability, 1000 cells were plated in 10 replicates on gelatine-coated 384-well plates in LIF containing medium and viability was measured at indicated time points using CellTiter-Glo (Promega) according to the manufacturer's protocol.
Animal experiments
Viable ESCs (3 × 10 6 cells in 100 μl PBS) were injected into the dorsal flank of 129P2/OlaHsd or Nod/SCID mice (age of 6-10 weeks). Teratomas were isolated 27 days after transplantation. For in vivo analysis, mice were injected i.p. with EdU (20 μg/g mouse) 2 h before sacrifice. Animal welfare and experimental procedures were performed in accordance to German animal protection law and were approved by the Regierungspräsidium Karlsruhe, Germany (AZ 35-9185.81/230/11).
Immunohistochemistry
Following deparaffination, antigen retrieval was performed by heating sections at 98°C for 10 min in 10 mM citrate buffer (pH 6.0). To block endogenous peroxidase, sections were treated with 3% H 2 O 2 for 20 min. After blocking with avidin/biotin blocking (Dako) solution at room temperature for 1 h. Sections were incubated with CD3 primary antibodies in blocking solution overnight at 4°C. Following washings with PBS, the slides were incubated with HRP-labeled secondary antibody for 3 h at room temperature. Incubation with Avidin/Biotin complex (Dako) was done for 30 min at room temperature, followed by incubation with diaminobenzidine substrate until brown color appeared. Counterstaining was performed with hematoxylin. Sections were mounted in Histofluid (Engelbrecht), and photographed using a Zeiss Axioskop 40 microscope.
FACS analysis
Teratomas were mechanically minced into small pieces using scalpels, followed by a digestion step for 2 h at 37°C in collagenase D at concentration of 2 mg/ml in RPMI medium supplemented by 10% FCS, Penicillin/Streptomycin (Invitrogen) and 2 mM Glutamine (Invitrogen). Gentle pipetting was performed during digestion. Cell suspensions were filtered through a 70 μm nylon filter mesh (BD), washed in PBS once, counted and processed for antibody staining and FACS analysis. For IL17 staining cells were stimulated with cell stimulation cocktail plus transport inhibitors (ebioscience) for 4 h at 37°C. FoxP3 stainings were performed according to FoxP3/Transcription Staining Buffer Set (ebioscience). Single cell suspensions from teratomas or cultured cells were stained with antibodies diluted in PBS containing 5% FCS for 45 min at 4°C. For intracellular labeling, cells were permeabilized either with 0.2% Triton X100/PBS for 5 min before incubation with conjugated primary antibodies or according to FoxP3/Transcription Staining Buffer Set. Secondary antibody staining was performed for non-fluorescent conjugated primary antibody. After staining, cells were fixed with 2% PFA for 10 min, washed and subsequently processed for FACS analysis. Proliferation and apoptosis assays were performed using EdU-Click iT reagent (Invitrogen) and PE Active Caspase-3 Apoptosis Kit (BD pharmingen), according to the manufacturer's instruction. Fluorescence data were obtained with a FACS LSRII (BD) with FACS Diva software. Data were subsequently analyzed using Flow Jo 10.1 software. Antibodies are listed in Table S1 , 2.
Western blot analysis
Cell pellets were lysed in urea buffer containing 8 M urea in PBS. Lysates were incubated on ice for 30 min and centrifuged at 3000 g for 15 min at 4°C. Supernatants were collected and protein concentrations were determined by BCA (Perbio, Thermo Scientific) according to the manufacturer's instructions. Proteins (15 μg) were supplemented with 5× Laemmli buffer and heated for 10 min at 80°C. Cell lysates were separated on 4-12% NuPage gradient gels Bis-Tris (Life Technologies) and transferred to PVDF membranes (Millipore, Merck Biosciences). In order to enrich Wnt proteins in cell culture supernatants medium was centrifuged at 15,000 g for 10 min to get rid of debris. Triton X100 (1% final) was added to the medium followed by addition of 50 μl blue sepharose beads (GE Healthcare) per 10 ml medium. Mix was incubated overnight at 4°C. After washing the beads three times (150 mm KCL, 50 mM Tris-Cl, 1% Triton X 100) the beads were resuspended in 2 × Laemmli buffer and heated for 5 min at 96°C. Supernatants were loaded on 4-12% NuPage gradient gels Bis-Tris (Life Technologies) and transferred to PVDF membranes (Millipore, Merck Biosciences). Membranes were blocked in 5% non-fat dry milk/PBS incubated overnight at 4°C with primary antibodies. Blots were then incubated with corresponding HRP-conjugated secondary antibodies (Sigma-Aldrich). Antibodies are listed in Table S1 , 2.
RNA, RT-PCR and expression profiling
Total RNA was extracted from ESCs and teratomas using RNAeasy extraction kit (Qiagen) according to the manufacturer's instructions. Reverse transcription and quantitative PCR was performed with 25 ng cDNA and LightCycler 480 Probes Master as described (Roche) (Primers were listed in Table S2 ). Relative mRNA expression was calculated as a fold change versus control. Teratomas were harvested 27 days after ESC injection and pulverized thoroughly in a mortar cooled with liquid nitrogen for further extraction of RNA.
Total RNA was isolated from each of the 10 teratoma samples using RNAeasy Kit (Qiagen) and labeled cRNA were prepared according to Illumina TotalPrep-RNA amplification protocol (P/N IL1791M, Life Technologies). 1.5 μg cRNA were hybridized for 17 h at 58°C on Illumina BeadChip Sentrix array (mouse WG-6 v2.0) according to Standard Illumina Hybridization protocol (#11322355). Gene expression microarrays were scanned using the Illumina iScan-Scanner according to Standard Illumina Scanning protocol, using BeadStudio software (v3.2). The limma package (v3.2.1), part of the Bioconductor/R package, was employed to test for differential expression (Wettenhall and Smyth, 2004) . This test assumes a linear model for gene expression levels. The differential expression test between Evi-GOF and control teratoma samples is based on the null hypothesis that the expression values of a gene in the samples come from the same distribution and results in p-values for each gene. A simple design matrix was created to fit a linear model to each gene expression value. An empirical Bayes method was used to moderate standard errors and estimate log fold change from the data, and a moderated tstatistic was used to assess differential expression. Genes which had an adjusted (Benjamini-Hochberg} p-value b 0.05 and absolute value of log 2 fold change greater than 1 were regarded as differentially expressed, and used for further PANTHER (Mi et al., 2005) (http:// www.pantherdb.org/) and TiGER (Liu et al., 2008) (http://bioinfo. wilmer.jhu.edu/tiger/) analysis. Analysis of the correlation of Evi and leukocyte markers was performed with R2: Genomics Analysis and Visualization Platform. http://hgserver1.amc.nl/cgi-bin/r2/main.cgi? &species=hs. Evi expression in germ cell tumors was analyzed in Oncomine, www.oncomine.com.
Statistical analysis
Unless otherwise indicated, data are expressed as mean ± SD. Statistical significance was calculated by a two-tailed Student's t-test with unequal variance. A p-value of b0.05 was considered statistically significant and marked in comparisons by asterisks. One asterisks represent p-values of b0.05. Two asterisks mark p-values of b 0.01.
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